Effect of aspirin and sulindac on methot
β
Daniel E. Furst; Ronald A. Herman; Rachelle Koehnke; Nils Ericksen; Linda Hash;
π
Article
π
1990
π
John Wiley and Sons
π
English
β 606 KB
The pharmacokinetics of low dose methotrexate (MTX) were evaluated in 12 rheumatoid arthritis patients in the presence and absence of steady-state levels of salicylic acid (ASA) and sulindac (SU). Using a Latin square design, patients were given MTX plus ASA (mean 3.4 g/day), MTX plus SU (mean 400 m